wherein said administration provides for selective killing of cancer cells by direct cytolysis and syncytia formation in cells that are susceptible to {HEAD ~ replication} of {TAIL ~ the fusogenic mutant} HSV 2 
of
wherein said administration provides for selective killing of cancer cells by direct cytolysis and syncytia formation in cells that are susceptible to { HEAD ~ replication } of { TAIL ~ the fusogenic mutant } HSV 2
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD REL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH